CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• CBFB gene mutations are common in solid tumors, particularly breast cancer, where it functions as a tumor suppressor.
• The precise tumor suppressive mechanisms of CBFB are not fully understood.
• Genetic interactions suggest a link between CBFB and TP53 in breast cancer.

Purpose of the Study:

• To elucidate the tumor suppressive function of CBFB in breast cancer.
• To investigate the functional relationship between CBFB and TP53 mutations.
• To identify downstream targets and pathways regulated by CBFB and p53.

Main Methods:

• Analysis of human breast cancer genomic datasets for genetic interactions.
• Integrated genomic studies to identify common transcriptional targets.
• Functional assays including gene re-expression and overexpression studies.
• Immunohistochemistry on xenografts to assess protein expression and proliferation.

Main Results:

• CBFB and TP53 mutations are mutually exclusive in breast cancer, indicating functional interplay.
• CBFB and p53 cooperate to maintain TAp73 expression; loss of either leads to TAp73 depletion.
• Restoring TAp73 expression counteracts the tumorigenic effects of CBFB deletion.
• TAp73 loss exacerbates tumorigenesis driven by NOTCH3 overexpression.
• TAp73 loss-of-expression is frequent in human breast cancer and correlates with increased proliferation.

Conclusions:

• CBFB and p53 collaborate to regulate TAp73, a key mediator of CBFB's tumor suppressive activity.
• This study reveals a novel CBFB-p53-TAp73 pathway critical for breast cancer suppression.
• Understanding this pathway offers new insights into breast cancer development and potential therapeutic strategies.